233 results
8-K
EX-1.1
CTIC
CTI BioPharma Corp
6 Apr 21
Entry into a Material Definitive Agreement
4:02pm
or any court, domestic or foreign, relating to the use, production, disposal or release of hazardous or toxic substances or relating … to the protection or restoration of the environment or human exposure to hazardous or toxic substances (collectively, “environmental laws”), owns or operates any real
8-K
EX-1.1
qjrjg7palt0hbb2w
15 Jan 21
Entry into a Material Definitive Agreement
5:27pm
8-K
EX-1.1
mh4n0zma5zo1cn49nb2e
15 Nov 19
Entry into a Material Definitive Agreement
4:15pm
8-K
EX-1.1
0my c4wa3k61gbvd
1 Nov 18
Entry into a Material Definitive Agreement
4:29pm
8-K
EX-99.1
x035zbc
13 Jan 15
Results of Operations and Financial Condition
12:00am
8-K
EX-99.1
ee3mwxwrfxdd4defkr2h
9 Dec 14
CTI BioPharma Announces Comprehensive Kinome Analysis that Demonstrates
12:00am
424B2
081mk4p9 8h0i5
6 Nov 14
Prospectus for primary offering
12:00am
8-K
EX-99.1
d608p6x1g 2d3b2t
16 Sep 14
This presentation includes forward-looking statements within the meaning of the Safe Harbor provisions of the Private
12:00am
8-K
EX-99.1
g2bcg46zs
1 Jul 14
CTI BioPharma Completes Recruitment in PERSIST-1 Pivotal Phase 3 Trial of Pacritinib for Patients with Myelofibrosis
12:00am